111 related articles for article (PubMed ID: 8947042)
1. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3.
Gotoh N; Tojo A; Shibuya M
EMBO J; 1996 Nov; 15(22):6197-204. PubMed ID: 8947042
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
Gotoh N; Toyoda M; Shibuya M
Mol Cell Biol; 1997 Apr; 17(4):1824-31. PubMed ID: 9121430
[TBL] [Abstract][Full Text] [Related]
3. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
4. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
6. Selective binding of shc-SH2 domain to tyrosine-phosphorylated zeta but not gamma-chain upon CD16 ligation on human NK cells.
Galandrini R; Palmieri G; Paolini R; Piccoli M; Frati L; Santoni A
J Immunol; 1997 Oct; 159(8):3767-73. PubMed ID: 9378963
[TBL] [Abstract][Full Text] [Related]
7. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
8. Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling.
Fournier E; Blaikie P; Rosnet O; Margolis B; Birnbaum D; Borg JP
Oncogene; 1999 Jan; 18(2):507-14. PubMed ID: 9927207
[TBL] [Abstract][Full Text] [Related]
9. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
10. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
[TBL] [Abstract][Full Text] [Related]
12. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
Rojas M; Yao S; Donahue JP; Lin YZ
Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
14. Shc dominant negative disrupts cell cycle progression in both G0-G1 and G2-M of ErbB2-positive breast cancer cells.
Stevenson LE; Ravichandran KS; Frackelton AR
Cell Growth Differ; 1999 Jan; 10(1):61-71. PubMed ID: 9950219
[TBL] [Abstract][Full Text] [Related]
15. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
Okuda K; Sato Y; Sonoda Y; Griffin JD
Int J Hematol; 2004 Feb; 79(2):138-46. PubMed ID: 15005341
[TBL] [Abstract][Full Text] [Related]
16. Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin.
Askew DS; Ihle JN; Cleveland JL
Blood; 1993 Oct; 82(7):2079-87. PubMed ID: 8400257
[TBL] [Abstract][Full Text] [Related]
17. Roles of paxillin phosphorylation in IL-3 withdrawal-induced Ba/F3 cell apoptosis.
Nah AS; Chay KO
Genes Genomics; 2019 Feb; 41(2):241-248. PubMed ID: 30604146
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to ``Chinese yam extract and adenosine attenuated LPS-induced cardiac dysfunction by inhibiting RAS and apoptosis via the ER-mediated activation of SHC/Ras/Raf1 pathway'' [Phytomedicine 61 (2019) /152857].
Zeng M
Phytomedicine; 2020 Sep; 76():153283. PubMed ID: 32711967
[No Abstract] [Full Text] [Related]
19. Cell signalling: SHC keeps ERK under control.
Wrighton KH
Nat Rev Mol Cell Biol; 2013 May; 14(5):266. PubMed ID: 23594952
[No Abstract] [Full Text] [Related]
20. The Configuration of GRB2 in Protein Interaction and Signal Transduction.
Wang D; Liu G; Meng Y; Chen H; Ye Z; Jing J
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
